12/2
10:24 am
jspr
Form SCHEDULE 13G Jasper Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
High
Report
Form SCHEDULE 13G Jasper Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
12/2
07:07 am
jspr
Form 8-K Jasper Therapeutics, For: Dec 02
High
Report
Form 8-K Jasper Therapeutics, For: Dec 02
11/14
05:23 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Qiming U.S. Healthcare Fund II, L.P.
Medium
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Qiming U.S. Healthcare Fund II, L.P.
11/14
12:19 pm
jspr
Form SCHEDULE 13G Jasper Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
Medium
Report
Form SCHEDULE 13G Jasper Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
11/12
01:05 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
Low
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
11/10
08:17 am
jspr
Form 10-Q Jasper Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Jasper Therapeutics, For: Sep 30
11/10
08:05 am
jspr
Form 8-K Jasper Therapeutics, For: Nov 10
High
Report
Form 8-K Jasper Therapeutics, For: Nov 10
11/7
12:45 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: MORGAN STANLEY
Medium
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: MORGAN STANLEY
9/24
04:02 pm
jspr
Form 4 Jasper Therapeutics, For: Sep 22 Filed by: WIGGANS THOMAS G
Medium
Report
Form 4 Jasper Therapeutics, For: Sep 22 Filed by: WIGGANS THOMAS G
9/24
04:02 pm
jspr
Form 4 Jasper Therapeutics, For: Sep 22 Filed by: Lucas Svetlana
Medium
Report
Form 4 Jasper Therapeutics, For: Sep 22 Filed by: Lucas Svetlana
9/24
04:01 pm
jspr
Form 4 Jasper Therapeutics, For: Sep 22 Filed by: MARTELL RON
Neutral
Report
Form 4 Jasper Therapeutics, For: Sep 22 Filed by: MARTELL RON
9/24
04:01 pm
jspr
Form 4 Jasper Therapeutics, For: Sep 22 Filed by: Shizuru Judith Anne
Neutral
Report
Form 4 Jasper Therapeutics, For: Sep 22 Filed by: Shizuru Judith Anne
9/23
05:08 pm
jspr
Form SCHEDULE 13D/A Jasper Therapeutics, Filed by: Velan Capital Investment Management LP
Medium
Report
Form SCHEDULE 13D/A Jasper Therapeutics, Filed by: Velan Capital Investment Management LP
9/19
04:38 pm
jspr
Form 8-K Jasper Therapeutics, For: Sep 18
Medium
Report
Form 8-K Jasper Therapeutics, For: Sep 18
9/19
04:36 pm
jspr
Form 424B5 Jasper Therapeutics,
Medium
Report
Form 424B5 Jasper Therapeutics,
9/18
04:46 pm
jspr
Form 424B5 Jasper Therapeutics,
High
Report
Form 424B5 Jasper Therapeutics,